(4) Treat obesity partly like a consumer market: direct-to-patient, cash channels, partnerships (telehealth/retail), and meet patients where they are. (5) Oral GLP-1 is positioned as market expansion (not just cannibalization): needle aversion + cold-chain friction are cited as key adoption drivers
The sports community is debating BPC-157 and other peptides constantly
Jeli wic kto jest na mocno dopitej redukcji i liczy kady gram cukru, musi bra pod uwag, e jeden baton wnosi 217 kcal i 15 g cukrw
Srskilt nr jag studerade det orangea kuvertet och konstaterade att det bara r ca 13 r kvar till pensionen och att jag drmed inte lngre ens r medellders
BYDUREON in Combination with Dapagliflozin versus BYDUREON Alone and Dapagliflozin Alone, All as Add-On to Metformin A 28-week double-blind comparator-controlled trial was conducted to compare the efficacy of BYDUREON and dapagliflozin (an SGLT2 inhibitor) to BYDUREON alone and dapagliflozin alone in patients with type 2 diabetes with inadequate glycemic control with metformin therapy (Trial 7 - NCT02229396)
The glucagon receptor component is hypothesised to increase energy expenditure and promote fat breakdown (lipolysis), potentially offering additional weight loss benefits